Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

4.73
BATS BZX Real-Time Price
As of 1:47pm ET
 -0.01 / -0.21%
Today’s Change
2.96
Today|||52-Week Range
24.88
-69.83%
Year-to-Date
3 Biotech Stocks That Could Soar Over the Next 12 Months
Jul 19 / MotleyFool.com - Paid Partner Content
5 Things Celldex Therapeutics, Inc. Wants You to Know
Jul 13 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close4.74
Today’s open4.75
Day’s range4.64 - 4.79
Volume38,309
Average volume (3 months)3,126,779
Market cap$467.9M
Dividend yield--
Data as of 1:47pm ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)+0.76%
Earnings growth (this year)-3.72%
Earnings growth (next 5 years)--
Revenue growth (last year)+52.82%
P/E ratioNM
Price/Sales277.69
Price/Book1.61

Competitors

 Today’s
change
Today’s
% change
GERNGeron Corp-0.03-0.94%
--Quidel Corp-0.29-1.63%
ALRPRBAlere Inc-10.00-2.86%
QDELQuidel Corp+0.79+4.04%
Data as of 1:35pm ET, 07/25/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$5.5M
Annual profit (last year)-$127.2M
Net profit margin-2,321.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
CFO, Secretary, Treasurer &
Senior Vice President
Avery W. Catlin
Corporate headquarters
Hampton, New Jersey

Forecasts

Partner Offers

Search for Jobs